The positivity of ER from primary tumor was 86% (89 out of 103 cases) and the positivity of PR from primary tumor was 55% (57 out of 103 cases) in recurrent high-grade serous carcinoma. The gene discussed is ESR1; the disease is serous adenocarcinoma.